Dow's $20B Sadara exit could remove $793M negative JV balance

For finance readers, Dow's potential exit from the $20 billion Sadara chemical JV is fundamentally a deconsolidation and capital allocation story. A sale to Aramco or financial sponsors could eliminate a $793 million negative investment balance, reduce geopolitical risk, and return cash to the core chemicals portfolio—but valuation and buyer appetite remain the key questions.

Bloomberg News reported on September 11, 2026 that Dow is considering an exit from its $20 billion chemicals partnership with Saudi Aramco, citing people familiar with the matter. The review centers on Dow's 35% stake in Sadara Chemical Co, a joint venture that operates one of the world's largest integrated chemical complexes in Jubail, Saudi Arabia. Neither Dow nor Aramco commented on the report, but the very existence of the discussions signals how prolonged industry weakness and Middle East conflict are reshaping global petrochemical strategies.

“

Bloomberg News reported on September 11, 2026 that Dow is considering an exit from its $20 billion chemicals partnership with Saudi Aramco, citing people familiar with the matter.

The backdrop is grim. The chemicals industry is contending with stagnant demand, higher production costs in Europe, changing regulatory requirements, and persistent global oversupply. The U.S.-Israeli war on Iran has compounded these pressures by disrupting oil and petrochemical flows, constraining supply chains, and raising transportation and operating costs. Dow said in July that the conflict had directly affected its joint ventures in the region, and Sadara's complex was temporarily halted earlier this year because of supply-chain disruptions. The Jubail facility has annual production capacity of more than three million metric tons of chemicals and plastics, making any operational or ownership change consequential for regional and global supply.

Dow's financial position in Sadara underscores the strain. As of June 30, 2026, Dow had a negative investment balance of $793 million in Sadara Chemical Co. Under equity-method accounting, a negative balance typically means cumulative losses have exceeded the carrying value of the investment, and Dow suspended recognition of losses from the joint venture during the first quarter of 2026. That accounting action implies that Sadara has been a source of ongoing losses; an exit could stop the bleed and potentially free management attention and capital for higher-return assets.

The potential deal structure is still fluid. Aramco could use a Dow exit to acquire the 35% stake outright, consolidating control of Sadara and integrating the complex more tightly with its crude-to-chemicals ambitions. Other strategic or financial investors could also bid. For Aramco, full ownership would align with its downstream expansion strategy, but it would also concentrate exposure to a global oversupply cycle. For Dow, a sale would mark another step in a multiyear portfolio review that has included European assets in 2024 and non-core holdings worldwide. In January 2026, Dow announced plans to cut 13% of its workforce as it seeks to improve profitability.

For investors, the story has both offensive and defensive dimensions. Offensively, a sale could generate proceeds and remove a loss-making venture from the perimeter. Defensively, it reduces geopolitical and operational risk in a region destabilized by conflict. Yet execution risk is real: the buyer pool may be narrow, valuation uncertain, and any transaction would require navigating complex regulatory and partnership arrangements. Aramco's potential interest could support pricing, but if Dow walks away entirely without a buyer, the negative investment balance could remain a lingering liability.